BIOCANCELL THERAPEUTICS INC. Shareholders' Equity
BIOCANCELL THERAPEUTICS INC. had Shareholders' Equity of -$661.00 thousand as of 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2012-05-10
- 2012-03-31: Stockholders' Equity Attributable to Parent -$661.00K.
- 2011-12-31: Stockholders' Equity Attributable to Parent -$3.50M.
- 2011-09-30: Stockholders' Equity Attributable to Parent -$1.48M.
- 2011-06-30: Stockholders' Equity Attributable to Parent -$523.00K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2012-03-31 | -$661.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$3.50M 10-Q · filed 2012-05-10 |
| 2011-09-30 | -$1.48M 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$523.00K 10-Q/A · filed 2011-08-30 |
| 2010-12-31 | $2.10M 10-K · filed 2012-03-30 |
| 2009-12-31 | -$3.37M 10-K · filed 2012-03-30 |
| 2008-12-31 | $1.95M 10-K · filed 2012-03-30 |
| 2007-12-31 | $2.53M 10-K · filed 2012-03-30 |
| 2006-12-31 | $6.02M 10-K · filed 2012-03-30 |
| 2005-12-31 | $1.43M 10-K · filed 2012-03-30 |
| 2004-12-31 | -$220.00K 10-K · filed 2012-03-30 |